Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 119

    1.

    Neuroblastoma: clinical perspectives, monoclonal antibodies, and retinoic acid.

    Seeger RC, Siegel SE, Sidell N.

    Ann Intern Med. 1982 Dec;97(6):873-84. Review.PMID: 6756240 [PubMed - indexed for MEDLINE]Related articles

    2.

    Apoptosis of N-type neuroblastoma cells after differentiation with 9-cis-retinoic acid and subsequent washout.

    Lovat PE, Irving H, Annicchiarico-Petruzzelli M, Bernassola F, Malcolm AJ, Pearson AD, Melino G, Redfern CP.

    J Natl Cancer Inst. 1997 Mar 19;89(6):446-52.PMID: 9091647 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The vitamin A analogues: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo.

    Ponthan F, Borgström P, Hassan M, Wassberg E, Redfern CP, Kogner P.

    Med Pediatr Oncol. 2001 Jan;36(1):127-31.PMID: 11464864 [PubMed - indexed for MEDLINE]Related articles

    4.

    Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-trans-retinoic acid.

    Lovat PE, Irving H, Annicchiarico-Petruzzelli M, Bernassola F, Malcolm AJ, Pearson AD, Melino G, Redfern CP.

    Eur J Cancer. 1997 Oct;33(12):2075-80.PMID: 9516856 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.

    Adamson PC.

    Leukemia. 1994;8 Suppl 3:S22-5.PMID: 7808020 [PubMed - indexed for MEDLINE]Related articles

    6.

    Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

    Rudnick E, Khakoo Y, Antunes NL, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, Stram DO, Matthay KK.

    Med Pediatr Oncol. 2001 Jun;36(6):612-22.PMID: 11344492 [PubMed - indexed for MEDLINE]Related articles

    7.

    Monoclonal antibody-based therapy for neuroblastoma.

    Cheung NK.

    Curr Oncol Rep. 2000 Nov;2(6):547-53. Review.PMID: 11122891 [PubMed - indexed for MEDLINE]Related articles

    8.

    9-cis-retinoic acid selectively activates the cellular retinoic acid binding protein-II gene in human neuroblastoma cells.

    Plum LA, Clagett-Dame M.

    Arch Biochem Biophys. 1995 Jun 1;319(2):457-63.PMID: 7786028 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid.

    Redfern CP, Lovat PE, Malcolm AJ, Pearson AD.

    Eur J Cancer. 1995;31A(4):486-94. Review.PMID: 7576951 [PubMed - indexed for MEDLINE]Related articles

    10.

    Increased retinoic acid receptor gamma expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells.

    Marshall GM, Cheung B, Stacey KP, Camacho ML, Simpson AM, Kwan E, Smith S, Haber M, Norris MD.

    Oncogene. 1995 Aug 3;11(3):485-91.PMID: 7630632 [PubMed - indexed for MEDLINE]Related articles

    11.

    Molecularly guided therapy of neuroblastoma: a review of different approaches.

    Tonini GP, Pistoia V.

    Curr Pharm Des. 2006;12(18):2303-17. Review.PMID: 16787256 [PubMed - indexed for MEDLINE]Related articles

    12.

    Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.

    Seeger RC, Reynolds CP, Gallego R, Stram DO, Gerbing RB, Matthay KK.

    J Clin Oncol. 2000 Dec 15;18(24):4067-76.PMID: 11118468 [PubMed - indexed for MEDLINE]Related articles

    13.

    A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.

    Engler S, Thiel C, Förster K, David K, Bredehorst R, Juhl H.

    Cancer Res. 2001 Apr 1;61(7):2968-73.PMID: 11306475 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effect of a new derivative of retinoic acid on proliferation and differentiation in human neuroblastoma cells.

    Bartolini G, Orlandi M, Ammar K, Magrini E, Ferreri AM, Rocchi P.

    Anticancer Res. 2003 Mar-Apr;23(2B):1495-9.PMID: 12820415 [PubMed - indexed for MEDLINE]Related articles

    15.

    Neuroblastoma.

    Shah S, Ravindranath Y.

    Indian J Pediatr. 1998 Sep-Oct;65(5):691-705. Review.PMID: 10773924 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.

    Adamson PC.

    Leukemia. 1994 Nov;8(11):1813-6. Review.PMID: 7967727 [PubMed - indexed for MEDLINE]Related articles

    17.

    9-cis retinoic acid--a better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma.

    Lovat PE, Irving H, Malcolm AJ, Pearson AD, Redfern CP.

    J Neurooncol. 1997 Jan;31(1-2):85-91.PMID: 9049833 [PubMed - indexed for MEDLINE]Related articles

    18.

    Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitro.

    Lovat PE, Lowis SP, Pearson AD, Malcolm AJ, Redfern CP.

    Neurosci Lett. 1994 Nov 21;182(1):29-32.PMID: 7891881 [PubMed - indexed for MEDLINE]Related articles

    19.

    Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cells.

    Veal GJ, Errington J, Redfern CP, Pearson AD, Boddy AV.

    Biochem Pharmacol. 2002 Jan 15;63(2):207-15.PMID: 11841795 [PubMed - indexed for MEDLINE]Related articles

    20.

    Induction of Ab3 and Ab3' antibody was associated with long-term survival after anti-G(D2) antibody therapy of stage 4 neuroblastoma.

    Cheung NK, Guo HF, Heller G, Cheung IY.

    Clin Cancer Res. 2000 Jul;6(7):2653-60.PMID: 10914706 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data